銀禧科技(300221.SZ):擬對銀禧特種材料增資
格隆匯8月8日丨銀禧科技(300221.SZ)公佈,根據公司中長期戰略發展規劃及未來市場需求,爲進一步拓廣公司高分子材料產品線、鞏固行業地位,公司召開第六屆董事會第十九次會議,審議通過《關於公司對子公司進行增資暨關聯交易的議案》,東莞市銀禧特種材料科技有限公司(簡稱“銀禧特種材料”)的股東將進行同比例增資,本次銀禧特種材料新增註冊資本1500萬元,其中公司以貨幣方式認繳出資1050萬元,東莞市德軒科技有限公司(簡稱“德軒科技”)以貨幣方式認繳出資450萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.